These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 17763218)

  • 21. Recurrence at three months and high-grade recurrence as prognostic factor of progression in multivariate analysis of T1G2 bladder tumors.
    Palou J; Rodríguez-Rubio F; Millán F; Algaba F; Rodríguez-Faba O; Huguet J; Villavicencio H
    Urology; 2009 Jun; 73(6):1313-7. PubMed ID: 19362341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cluster analysis of p53 and Ki67 expression, apoptosis, alpha-fetoprotein, and human chorionic gonadotrophin indicates a favorable prognostic subgroup within the embryonal carcinoma germ cell tumor.
    Mazumdar M; Bacik J; Tickoo SK; Dobrzynski D; Donadio A; Bajorin D; Motzer R; Reuter V; Bosl GJ
    J Clin Oncol; 2003 Jul; 21(14):2679-88. PubMed ID: 12860944
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aneuploidy and overexpression of Ki67 and p53 as markers for neoplastic progression in Barrett's esophagus: a case-control study.
    Sikkema M; Kerkhof M; Steyerberg EW; Kusters JG; van Strien PM; Looman CW; van Dekken H; Siersema PD; Kuipers EJ
    Am J Gastroenterol; 2009 Nov; 104(11):2673-80. PubMed ID: 19638963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
    Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N
    Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prognostic study of cell proliferative markers ki67, PCNA and p53 oncoprotein in bladder tumors].
    Ben Rejeb A; Mahjoub A; Berraies N; Tissaoui K
    Ann Urol (Paris); 2000 Aug; 34(4):240-8. PubMed ID: 10994143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The predictive value of muscularis mucosae invasion and p53 over expression on progression of stage T1 bladder carcinoma.
    Bernardini S; Billerey C; Martin M; Adessi GL; Wallerand H; Bittard H
    J Urol; 2001 Jan; 165(1):42-6; discussion 46. PubMed ID: 11125360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Altered p53 and pRb expression is predictive of response to BCG treatment in T1G3 bladder cancer.
    Cormio L; Tolve I; Annese P; Saracino A; Zamparese R; Sanguedolce F; Bufo P; Battaglia M; Selvaggi FP; Carrieri G
    Anticancer Res; 2009 Oct; 29(10):4201-4. PubMed ID: 19846973
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The p53 positivity in non-tumor mucosa in patients with superficial urinary bladder cancer].
    Soukup V; Babjuk M; Dusková J; Pesl M; Szakácsova M; Zámefnik L; Dvorácek J
    Cas Lek Cesk; 2007; 146(1):63-7. PubMed ID: 17310587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p53 and microvessel density in primary resection specimens of superficial bladder cancer.
    Reiher F; Ozer O; Pins M; Jovanovic BD; Eggener S; Campbell SC
    J Urol; 2002 Mar; 167(3):1469-74. PubMed ID: 11832772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
    Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T;
    Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The relationship of the histologic grade at the deep invasive front and the expression of Ki-67 antigen and p53 protein in oral squamous cell carcinoma.
    Kurokawa H; Zhang M; Matsumoto S; Yamashita Y; Tanaka T; Tomoyose T; Takano H; Funaki K; Fukuyama H; Takahashi T; Sakoda S
    J Oral Pathol Med; 2005 Nov; 34(10):602-7. PubMed ID: 16202080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictive value of p53 and pRb expression in superficial bladder cancer patients treated with BCG and interferon-alpha.
    Esuvaranathan K; Chiong E; Thamboo TP; Chan YH; Kamaraj R; Mahendran R; Teh M
    Cancer; 2007 Mar; 109(6):1097-105. PubMed ID: 17311305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Establishment of the prognostic evaluation system of T1G3 bladder urothelial cancer].
    Li XD; Sun G; Liu XQ
    Zhonghua Wai Ke Za Zhi; 2013 Aug; 51(8):741-5. PubMed ID: 24252684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bladder tumor infiltrating mature dendritic cells and macrophages as predictors of response to bacillus Calmette-Guérin immunotherapy.
    Ayari C; LaRue H; Hovington H; Decobert M; Harel F; Bergeron A; Têtu B; Lacombe L; Fradet Y
    Eur Urol; 2009 Jun; 55(6):1386-95. PubMed ID: 19193487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospective evaluation of p53 as a prognostic marker in T1 transitional cell carcinoma of the bladder.
    Dalbagni G; Parekh DJ; Ben-Porat L; Potenzoni M; Herr HW; Reuter VE
    BJU Int; 2007 Feb; 99(2):281-5. PubMed ID: 17155984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined-modality treatment and organ preservation in bladder cancer. Do molecular markers predict outcome?
    Weiss C; Rödel F; Wolf I; Papadopoulos T; Engehausen DG; Schrott KM; Sauer R; Rödel C
    Strahlenther Onkol; 2005 Apr; 181(4):213-22. PubMed ID: 15827690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. P16 immunoreactivity is an independent predictor of tumor progression in minimally invasive urothelial bladder carcinoma.
    Krüger S; Mahnken A; Kausch I; Feller AC
    Eur Urol; 2005 Apr; 47(4):463-7. PubMed ID: 15774242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of p53 overexpression in T1G3 bladder tumors treated with bacillus Calmette-Guérin therapy.
    Peyromaure M; Weibing S; Sebe P; Verpillat P; Toublanc M; Dauge MC; Boccon-Gibod L; Ravery V
    Urology; 2002 Mar; 59(3):409-13. PubMed ID: 11880082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Role of Ki-67, mutated gene-suppressor p53 and HER-2neu oncoprotein in the prognosis for the clinical course of bladder cancer].
    Masliukova EA; Pozharisskiĭ KM; Karelin MI; Startsev VIu; Ten VP
    Vopr Onkol; 2006; 52(6):643-8. PubMed ID: 17338241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic significance of Ki-67 and p53 as tumor markers in salivary gland malignancies in Finland: an evaluation of 212 cases.
    Luukkaa H; Klemi P; Leivo I; Vahlberg T; Grénman R
    Acta Oncol; 2006; 45(6):669-75. PubMed ID: 16938809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.